Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,045 | 28,918 | 17,116 | 19,055 | 20,818 |
| TOTAL | $16,426 | $29,511 | $17,943 | $21,570 | $30,337 |
| Non-Current Assets | |||||
| PPE Net | 367 | 607 | 872 | 905 | 494 |
| Other Non-Current Assets | 442 | 23 | 23 | 23 | 14 |
| TOTAL | $809 | $630 | $895 | $928 | $508 |
| Total Assets | $17,235 | $30,141 | $18,838 | $22,498 | $30,845 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,315 | 1,034 | 2,020 | 1,993 | 4,413 |
| Accrued Expenses | 2,711 | 2,251 | 3,600 | 2,940 | 574 |
| Other current liabilities | N/A | 99 | 4,173 | 14,824 | 10,588 |
| TOTAL | $5,275 | $3,384 | $9,793 | $19,757 | $15,575 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 13,094 | 12,652 | 12,773 | 1,040 | 1,315 |
| TOTAL | $13,017 | $12,598 | $12,455 | $492 | $267 |
| Total Liabilities | $18,292 | $15,982 | $22,248 | $20,249 | $15,842 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68 | 62 | 15 | 13 | 10 |
| Common Shares | 17 | 15 | 4 | 117 | 91 |
| Retained earnings | -235,537 | -219,461 | -194,170 | -172,034 | -144,779 |
| Other shareholders' equity | 1,883 | 2,851 | -1,914 | -1,596 | -1,048 |
| TOTAL | $-1,057 | $14,159 | $-3,410 | $2,249 | $15,003 |
| Total Liabilities And Equity | $17,235 | $30,141 | $18,838 | $22,498 | $30,845 |